COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,389 Articles (22,816 medRxiv, 8,573 bioRxiv)

Most recent first Previous |  Page 52: Articles 511-520  | Next

Post-pandemic mortality patterns and COVID-19 burden considering multiple death causes
Riedmann, U., Levitt, M., Pilz, S., Ioannidis, J.
10.1101/2025.09.01.25334892 — Posted: 2025-09-06
Pan-microbiome analysis along the human respiratory axis reveals an ecological continuum in health and collapse in disease
Shinde, T., Kumpitsch, C., Zhang, Y., Franzosa, E. A., Mohammadzadeh, R., Weinberger, V., Eagan, T. M., Huttenhower, C., Foris, V., Moissl-Eichinger, C.
10.1101/2025.09.04.674177 — Posted: 2025-09-04
Coronavirus NSP14 Drives Internal m7G Modification to Rewire Host Splicing and Promote Viral Replication
Saenz Altamirano, E. E., Huang, C.-H., Tsai, Y.-L., Tzeng, T. J., Borges Teruel, N. F., Pandey, I., Oswal, N., Chen, Y. G., Chang, C.-W., Rajsbaum, R., Wong, L. Y. R., Correa, I. R., Hsu, J. C.-C.
10.1101/2025.09.03.673802 — Posted: 2025-09-03
Respiratory viral infections prime accelerated lung cancer growth
Sun, J., Qian, W., Wei, X.
10.1101/2025.09.02.672566 — Posted: 2025-09-03
Capturing the Mutational Dynamics of SARS-CoV-2 with Graphs
Das, B., Heath, L. S.
10.1101/2025.09.02.673804 — Posted: 2025-09-03
Computational and Experimental Identification of Potential Neutralizing Peptides Derived from Human ACE2 Against SARS-CoV-2 Infection
Yao, Q., Mahase, V., Hou, W.-H., Cruz-Cosme, R., Tang, Q., Teng, S.
10.1101/2025.09.01.673483 — Posted: 2025-09-02
Targeted degradation of SARS-CoV-2 via the autophagy-lysosome system using chemical mimetics of the N-degron pathway
Lee, G. E., Bae, T. H., Park, U., Lee, J., Lee, D. W., Song, Y. J., Gu, S. H., Yu, C. H., Kim, M., Martinez-Sobrido, L., Choi, M., Park, J.-G., Cho, N.-H., Sung, K. W., Kwon, Y. T.
10.1101/2025.09.01.673409 — Posted: 2025-09-02
Excitability as a Design Principle in the Immune System
Lebel, Y., Alon, U.
10.1101/2025.08.31.673412 — Posted: 2025-09-02
Determinants of Natural Killer Cell-Mediated Antibody Dependent Cellular Cytotoxicity in SARS-CoV-2 Antibodies
Depierreux, D. M., Ruiz, F. M., Lilly, M., Guenthoer, J., Chohan, V., Overbaugh, J.
10.1101/2025.08.28.672949 — Posted: 2025-08-29
Integrated phenotypic screening and chemical proteomics identifies ETF1 ligands that modulate viral translation and replication
Kim, A., Ma, K., Reinhardt, C. J., Lazar, D. C., Ogasawara, D., Shaw, T. M., de la Torre, J. C., Bailey, A. L., Melillo, B., Teijaro, J. R., Cravatt, B. F.
10.1101/2025.08.27.672717 — Posted: 2025-08-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).